Articles récents

• OncNGS has entered in prototyping phase (Phase 2) with the selection of three innovative approaches for future Next-Generation Sequencing (NGS) tests for cancer
• Update on the current stage of the oncNGS Pre-Commercial Procurement procedure
• The oncNGS consortium selects 4 innovative ideas for the research and development of Next Generation Sequencing solutions for cancer tests
• The oncNGS call for tenders is open!
• oncNGS Suppliers Information Day 29.06.2022 – Video and presentation available!